Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Obesidad mórbida y desenlaces materno-fetales

Morbid obesity and fetal-maternal outcomes.

Ginecol Obstet Mex. 2019 octubre;87(10):647-659.

https://doi.org/10.24245/gom.v87i10.3182

Cristina Rodríguez-Vidal,1 Esther Álvarez-Silvares,2 Roberto Rodríguez-Núñez,3 Marta Pérez-Adán,3 María Teresa Alves-Pérez4

1 Médico interno residente, Hospital de Cruces, España.
2 Jefa de la Sección de Obstetricia, Complexo Hospitalario Universitario de Ourense, España.
3 Especialista en Obstetricia y Ginecología, Complexo Hospitalario Universitario de Ourense, España.
4 Unidad de Apoyo a la Investigación, Colegio Oficial de Médicos de Ourense, España.


Corrrespondencia:

Esther Álvarez Silvares
esther.alvarez.s@gmail.com

Debe citarse como:

Rodríguez-Vidal C, Álvarez-Silvares E, Rodríguez-Núñez R, Pérez-Adán M, Alves-Pérez MT. Obesidad mórbida y desenlaces materno-fetales. Ginecol Obstet Mex. 2019 octubre;87(10):647-659. https://doi.org/10.24245/gom.v87i10.3182

Resumen

OBJETIVO: Establecer si la obesidad mórbida durante el embarazo se asocia con incremento de la morbilidad y mortalidad materna y perinatal versus mujeres con peso normal.

MATERIALES Y MÉTODOS: Estudio de cohortes, con seguimiento prospectivo, ambispectivo, con recolección de datos de las historias clínicas de pacientes atendidas en el Complexo Hospitalario de Ourense, España (2014- 2017). Se incluyeron pacientes embarazadas con obesidad mórbida y con peso normal, y se asignaron al azar para su comparación. Para determinar la asociación potencial entre las variables, y para detectar su relación o interacción, se efectuaron pruebas paramétricas y no paramétricas.

RESULTADOS: Se estudiaron 139 mujeres (48 embarazadas con obesidad mórbida y 91 sin obesidad) y se encontró incremento en la incidencia anual de embarazadas con obesidad mórbida (IMC ≥ 40 kg/m2) en quienes se registró mayor propensión a padecer estados hipertensivos del embarazo e hipotiroidismo gestacional, con diferencia estadística a favor de la inducción del parto y terminación del embarazo mediante cesárea (riesgo de 4.29; IC95%: 2.02-9.08). En cuanto a los desenlaces neonatales, la cohorte con obesidad tuvo más recién nacidos macrosómicos, valores alterados en el Apgar al primer minuto e ingreso del recién nacido a cuidados intensivos.

CONCLUSIONES: En nuestro medio se ha incrementado la incidencia de mujeres embarazadas con obesidad mórbida. La obesidad clase III durante el embarazo incrementa el riesgo de complicaciones materno-fetales.

PALABRAS CLAVE: Obesidad, mórbida; peso normal; mujeres embarazadas; hipertensión inducida por el embarazo; diabetes gestacional; índice de masa corporal.

Abstract

OBJECTIVE: Establish whether morbid obesity during pregnancy is associated with increased maternal and perinatal morbidity and mortality (gestational diabetes, hypertensive states of pregnancy, premature delivery, fetuses with intrauterine growth retardation, macrosomia, neonatal death, etc.) in comparison with women with normal weight.

MATERIALS AND METHODS: Cohort study, with prospective follow-up and ambispective data collection of the Clinical History in the Ourense´s Hospital (Spain) between 2014 and 2017. Pregnant women with morbid obesity and non-obese random pregnant women were included for comparison. Parametric /nonparametric tests were performed to determine the potential association between the variables and to detect the relationship or interaction between the different variables, as well as the correlations.

RESULTS: A total of 139 women were included (48 pregnant women with morbid obesity and 91 pregnant women without obesity). There was an increase in the annual incidence of pregnant women with morbid obesity. Patients with BMI ≥ 40 Kg/m2 were significantly more likely to have gestational diabetes, requiring insulin therapy more frequently. A greater propensity to develop hypertensive states of pregnancy (mainly gestational hypertension) and gestational hypothyroidism. We found statistical differences in favor of induction and delivery by caesarean section in pregnant women with morbid obesity. There was a risk of 4.29 (95% CI:2.02-9.08) of a woman with morbid obesity ending her pregnancy by caesarean section. It stands out in the neonatal results, that the cohort with obesity presented an increase of macrosomic newborns, altered values ​​of the Apgar test at the first minute and neonatal admission.

CONCLUSIONS: The incidence of pregnant women with morbid obesity in our environment has increased. Class III obesity during pregnancy increases the risk of maternal-fetal complications.

KEYWORDS: Obesity, morbid; Normal weight; Pregnant women; Hypertension, pregnancy-induced; Diabtes, gestational; Body Mass Index.

    1. James WP. WHO recognition of the global obesity epidemic. Int J Obes. 2008;32(Suppl 7). https://doi.org/10.1038/ijo.2008.247
    2. Organización Mundial de la Salud. Diez datos sobre la obesidad. 2017 (Internet) (Citado el 11/7/2019). https://www.who.int/features/factfiles/obesity/es/
    3. Organización Mundial de la Salud. Obesidad y Sobrepeso. 2017 (Internet) (Citado el 08/04/2019). Disponible en: http://www.who.int/mediacentre/factsheets/fs311/es/
    4. Salas-Salvadó J, et al. Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Med Clin. 2007;128(5):184-96. https://doi.org/10.1016/S0025-7753(07)72531-9
    5. La Coursiere DY, et al. Population-based trends and correlates of maternal overweight and obesity, Utah 1991-2001. Am J Obstet Gynecol. 2005;192(3):832-9. https://doi.org/10.1016/j.ajog.2004.11.034
    6. Yeh J, et al. Increasing prepregnancy body mass index: analysis oftrends and contributing variables.Am J Obstet Gynecol. 2005;193(6):1994-98. https://doi.org/10.1016/j.ajog.2005.05.001
    7. Gallo JL, et al. Síndrome metabólico en Obstetricia. Clin Invest Gin Obstet. 2010;37(6):239-45. https://www.elsevier.es/es-revista-clinica-e-investigacion-ginecologia-obstetricia-7-articulo-sindrome-metabolico-obstetricia-S0210573X10000614
    8. González-Moreno J, et al. Obesidad y embarazo. Rev Med MD. 2013;4(4):269-275.
    9. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93(11 Suppl 1). doi: 10.1210/jc.2008-1613
    10. Bloom SL, et al. Obesidad. En: Williams Obstetricia. Capítulo 48: edición 24. México: Médica Panamericana, 2016; 564-602.
    11. Challier JC, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008;29(3):274-81. doi: 10.1016/j.placenta.2007.12.010
    12. Stewart FM, et al. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab.2007;92(3):969-75. https://doi.org/10.1210/jc.2006-2083
    13. Zavalza-Gómez AB, et al. Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract. 2008;80(1):8-15. doi: 10.1016/j.diabetes.2007.12.012
    14. Nelson SM, et al. Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Hum Reprod Update. 2010;16(3):255-75. doi: 10.1093/humupd/dmp050
    15. WHO. Programme of Nutrition, Family and Reproductive Health. Obesity. Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, 3-5 June, 1997. Geneva: WHO; 1998.
    16. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019 Jan;133(1). doi: 10.1097/AOG.0000000000003018.
    17. Protocolos Sociedad Española de Ginecología y Obstetricia. Amenaza de parto pretermino. 2014 (Citado 19/6/2019). https://sego.es/db/download.php?doc=2369328.
    18. Grupo Español de Diabetes y Embarazo (GEDE). Documento de consenso: Asistencia a la gestante con diabetes. Guía práctica actualizada en 2014. Av Diabetol. 2015;31(2):45-59. DOI: 10.1016/j.avdiab.2014.12.001
    19. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28(12):1039-57. https://doi.org/10.2337/diab.28.12.103932.
    20. Dodd JM, et al. LIMIT Randomised Trial Group. Antenatal life style advice for women who are overweight or obese: LIMIT randomised trial. BMJ. 2014;348. doi: 10.1136/bmj.g128533.
    21. Poston L, et al. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomized controlled trial. Lancet Diabetes Endocrinol. 2015;3(10):767-77. doi: 10.1016/S2213-8587(15)00227-2.
    22. Chiswick C, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015;3(10):778-86. doi: 10.1016/S2213-8587(15)00219-3.
    23. Dodd JM, et al. Metformina para mujeres con sobrepeso u obesidad durante el embarazo para mejorar los resultados maternos e infantiles. Base de Datos Cochrane de Revisiones Sistemáticas 2018, Número 7. Art. No.: CD010564. doi: 10.1002/14651858.CD010564.pub2.
    24. Viswanathan M, et al. Outcomes of maternal weight gain. Evid Rep Technol Assess. 2008; 168:1-223. https://www.ncbi.nlm.nih.gov/books/NBK38595/
    25. Hung TH, et al. Gestational weight gain and risks for adverse perinatal outcomes: a retrospective cohort study based on the 2009 Institute of Medicine Guidelines. Taiwan J Obstet Gynecol. 2015;54:421-5. doi: 10.1016/j.tjog.2015.06.01038.
    26. Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the mother and her offspring. Br J Obstet Gynecol. 2006;113: 1126-33. doi: 10.1111/j.1471-0528.2006.00989.x
    27. Torloni MR, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009;10:194-203. doi: 10.1111/j.1467-789X.2008.00541.x
    28. Scott-Pillai R, et al. The impact of body mass index on maternal and neonatal outcomes: a retrospective study in a UK obstetric population, 2004-2011. BJOG. 2013;120:932-9. doi: 10.1111/1471-0528.12193.
    29. Lutsiv O, et al. The effects of morbid obesity on maternal and neonatal health outcomes: a systematic review and meta-analyses. Obesity reviews. 2015;16: 531-46. doi: 10.1111/obr.12283
    30. Lockwood CJ, et al. Decidual cell regulation of natural killer cell-recruiting chemokines: implications for the pathogenesis and prediction of preeclampsia. Am J Pathol. 2013; 183:841. doi: 10.1016/j.ajpath.2013.05.029
    31. Van Der Linden EL, et al. Maternal body mass index and adverse pregnancy outcomes: a Ghanaian cohort study. Obesity. 2016;24:215-22. doi: 10.1002/oby.21210
    32. McDonald SD, et al. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ. 2010 Jul 20;341. doi: 10.1136/bmj.c3428.
    33. Aly H, et al. Maternal obesity, associated complications and risk of prematurity. J Perinatol 2010;30(7):447-51. doi: 10.1038/jp.2009.117
    34. Briese V, et al. Risks of pregnancy and birth in obese primiparous women: An analysis of German perinatal statistics. Arch Gynecol Obstet. 2011;283(2):249-53. doi: 10.1007/s00404-009-1349-9
    35. Zhong Y, et al. The association between prepregnancy maternal body mass index and preterm delivery. Am J Perinat. 2010;27(4):293-8. doi: 10.1055/s-0029-1241736
    36. El-Chaar D, et al. The impact of increasing obesity class on obstetrical outcomes. JOGC. 2013;35:224-33. doi: 10.1016/S1701-2163(15)30994-4
    37. Brost BC, et al. The Preterm Prediction Study: association of cesarean delivery with increases in maternal weight and body mass index. Am J Obstet Gynecol. 1997;177:333. https://www.ajog.org/article/S0002-9378(97)70195-9/fulltext
    38. Heslehurst N, et al. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: A meta-analysis. Obes Rev. 2008;9(6):635-83. doi: 10.1111/j.1467-789X.2008.00511.x
    39. Ehrenberg HM, et al. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol. 2004;191: 969-74. doi: 10.1016/j.ajog.2004.06.057
    40. Kominiarek MA, Zhang J, Vanveldhuisen P. Contemporary labor patterns: the impact of maternal body mass index. Am J Obstet Gynecol. 2011; 205:244. doi: 10.1016/j.ajog.2011.06.014.
    41. Abenhaim HA, et al. Effect of prepregnancy body mass index categories on obstetrical and neonatal outcomes. Arch Gynecol Obstet. 2007;275(1):39-43. doi: 10.1007/s00404-006-0219-y
    42. Trojner Bregar A, et al. A dose–response relation exists between different classes of pre-gravid obesity and selected perinatal outcomes. Arch Gynecol Obstet. 2017;296(3):465-68. doi: 10.1007/s00404-017-4441-6.
    43. Mc Keating A, et al. The clinical outcomes of unplanned pregnancy in severely obese women. J Matern Fetal Neonatal Med. 2016;29(4):646-50. doi: 10.3109/14767058.2015.1015414
    44. Ricart W, et al. Body mass index has a greater impact on pregnancy out comes tan gestational hyperglycaemia. Diabetologia. 2005; 48:1736-42. doi: 10.1007/s00125-005-1877-1
    45. Lowe WL Jr, et al. Maternal BMI and glycemia impact the fetal metabolome. Diabetes Care. 2017; 40: 902. doi: 10.2337/dc16-245268.
    46. Dodd JM, et al. Maternal and perinatal health outcomes by body mass index category. Aust N Z J Obstet Gynaecol. 2011; 51:136-40. doi: 10.1111/j.1479-828X.2010.01272.x.
    47. Blomberg M. Maternal Obesity, Mode of Delivery, and Neonatal Outcome. Obstet Gynecol. 2015;122(1):50-5. doi: 10.1097/AOG.0b013e318295657f.
    48. Flenady V, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011;16;377(9774):1331-40. doi: 10.1016/S0140-6736(10)62233-7
    49. Bodnar LM, et al. Maternal prepregnancy obesity and cause specific stillbirth. Am J Clin Nutr. 2015;102 (4):858-64. doi: 10.3945/ajcn.115.112250

Comentarios